Heerlen, NL, 29 Dec 2017 14:30 CET
Royal DSM (AEX: DSM.AS), a global science-based company active in health, nutrition and materials and Amyris, Inc. (Nasdaq: AMRS), the industrial bioscience company, today announced that they have closed the transaction for the sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris’s high-volume products.
The announcement of the intended transaction was made on 17 November 2017 and the details can be found here.
Herman Betten
Global Director External Communications
+31 45 578 2420
media.contacts@dsm.com
Dave Huizing
DSM Investor Relations
+31 45 578 2864
investor.relations@dsm.com
Peter DeNardo
Amyris, Inc.
+1 (510) 740 7481
investor@amyris.com
